![Jeremy Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeremy Levin
Directeur Général chez
OPTHEA LIMITED
Fortune : 15 M $ au 31/03/2025
Profil
Jeremy Max Levin is the founder of Ovid Therapeutics, Inc., founded in 2014, serving as Executive Chairman since 2026.
Current jobs include Chairman & Chief Executive Officer at Opthea Ltd. since 2025, Director at Biotechnology Innovation Organization since 2021, and Advisor at New Rhein Healthcare Investors.
Former jobs include President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2012 to 2013, Chairman & Chief Executive Officer at Cadus Corp.
from 1992 to 1998, Chief Executive Officer at Physiome Sciences, Inc. from 1998 to 2003, Director at ZymoGenetics, Inc. in 2010, Independent Non-Executive Director at Biocon Ltd. from 2015 to 2020, Director at The Biotechnology Institute, Director at New York Biotechnology Association, Inc., Director at ZappRx, Inc., Independent Director at H.
Lundbeck A, SVP-Strategy, Alliances & Transactions at Bristol Myers Squibb Co. from 2007 to 2012, and Global Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2002 to 2007.
Education includes undergraduate degree conferred in 1974 and graduate and doctorate degrees from the University of Oxford, and a doctorate degree from the University of Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OVID THERAPEUTICS INC. 2,02 % | 17/04/2026 | 3 770 509 ( 2,02 % ) | 10 M $ | 31/05/2026 |
OPTHEA LIMITED 1,09 % | 23/06/2026 | 13 409 685 ( 1,09 % ) | 5 M $ | 31/03/2025 |
Postes actifs de Jeremy Levin
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Fondateur | 01/04/2014 |
| OPTHEA LIMITED | Directeur Général | 01/09/2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 14/06/2021 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Consultant / Advisor | - |
Anciens postes connus de Jeremy Levin
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCON LIMITED | Directeur/Membre du Conseil | 01/01/2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Directeur Général | 30/10/2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/01/2007 |
Physiome Sciences, Inc.
 Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development | President | - |
Formation de Jeremy Levin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Cadus Corp.
 Cadus Corp. BiotechnologyHealth Technology Provides drug research services | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biocon Ltd.
 Biocon Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Physiome Sciences, Inc.
Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development | Commercial Services |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Commercial Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
Choisissez Zonebourse 
